Zupiflex-TH Tablet is a combination pharmaceutical formulation containing Aceclofenac 100mg and Thiocolchicoside 4mg, designed for the management of musculoskeletal pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and swelling. Thiocolchicoside, a muscle relaxant with anti-inflammatory and analgesic properties, acts as a selective antagonist of GABA and glycine receptors, providing relief from muscle spasms and associated discomfort. The combined action of these agents makes Zupiflex-TH effective in treating conditions such as acute musculoskeletal disorders, low back pain, osteoarthritis, and other inflammatory rheumatic diseases. It is typically prescribed for short-term use to alleviate pain and improve mobility. Patients should use this medication under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, gastrointestinal ulcers, or severe hepatic or renal impairment. Common adverse effects may include gastrointestinal disturbances, dizziness, or allergic reactions. Zupiflex-TH Tablet should be taken with food to minimize gastrointestinal irritation, and patients are advised to report any unusual symptoms promptly. This combination therapy offers a balanced approach to pain management by addressing both inflammation and muscle spasm components.